Today, 3rd November 2020 Icon Cancer Centre – Singapore alongside our partners at Mt Alvernia Hospital held a ground-breaking ceremony for the new state-of-the-art integrated cancer centre set to open early 2022. The $25 million facility will provide a holistic approach to cancer care, bringing together medical oncology, haematology and radiation oncology for adults and children, and will be a centre of excellence for the ongoing improvement of healthcare across the region.
Founded on Catholic values by the Sisters from the Franciscan Missionaries of the Divine Motherhood (FMDM) in 1961, Mount Alvernia Hospital is a 305-bed, not-for-profit general acute care private hospital that has delivered quality healthcare to the local community for 58 years. With a mission of providing excellent and holistic healthcare, Mount Alvernia Hospital and Icon share the same patient-centred values, utilising the latest technologies and expert medical specialist teams to deliver the best care possible.
The new centre will offer an oncology hospital delivering, chemotherapy, immunotherapy and targeted therapy, along with a single radiation therapy bunker, on-site PET-CT, pathology and pharmacy services. It will have the capacity to treat up to 1000 patients a year, including the 25% of patients who require concurrent chemotherapy and radiation treatment.
Icon ASEAN CEO, Serena Wee said this centre marks a significant milestone in Singapore’s healthcare system and a momentous time in Icon and Mount Alvernia’s partnership.
“I’m proud to stand here today as our joint vision of improved cancer care comes to fruition. The development of this integrated cancer centre is a testament to Icon and Mt Alvernia’s shared dedication to deliver a comprehensive approach to cancer treatment for the benefit of patients and their families. Together with Mt Alvernia we are delivering a truly integrated cancer centre unique to the Singapore private healthcare landscape,” said Serena Wee.
The centre will also offer the full suite of patient services including palliative medicine and Icon’s Young Women’s Cancer Program, which supports young female cancer patients throughout their cancer journey.
